Greenland Mines (NASDAQ: GRML) announced that independent consultant SLR Consulting (Canada) Ltd. has completed the first U.S. Securities and Exchange Commission S-K 1300-compliant Technical Report Summary for the Skaergaard project in southeast Greenland. The updated 2026 Mineral Resource Estimate, effective July 3, 2026, shows a 31% increase in indicated contained palladium equivalent (PdEq) metal to 15.0 million ounces, with indicated grade rising 36% to 3.04 g/t PdEq. Inferred contained PdEq metal also increased 24% to 17.49 million ounces compared to the 2022 resource estimate.
The company attributed the upgraded resource to improved geological modeling and updated metal price assumptions, including gold at $3,500 per ounce. The S-K 1300 compliance provides the regulatory foundation to advance toward an Initial Assessment, a key step in project development. Greenland Mines noted that its 2026 field program is underway, with drilling, bulk sampling, engineering, environmental and geotechnical work designed to support evaluation of both open-pit and underground mining scenarios at the Skaergaard project.
This resource upgrade is significant for Greenland Mines as it strengthens the project's economic potential. The Skaergaard project is a key asset in the company's mining division, which also includes the Sarfartoq neodymium-praseodymium rare earths project in southwest Greenland, subject to closing of a previously announced transaction. The company's strategy focuses on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
The updated estimate comes as demand for palladium and other platinum group metals continues to be driven by automotive catalytic converters and industrial applications. Greenland Mines is a Nasdaq-listed company with two operating divisions: mining and biotech. The biotech division includes Klotho’s KLTO‑202 primary indication for ALS. For more information, visit the company's newsroom at https://ibn.fm/GRML.
The full press release is available at https://ibn.fm/qqEBp. This news matters because it validates the Skaergaard project's resource base, potentially leading to increased investment and development activity in Greenland's mining sector, which could have implications for global palladium supply chains and the local economy.
